Vectormune FP ILT Europese Unie - Hongaars - EMA (European Medicines Agency)

vectormune fp ilt

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - csirke - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Strangvac Europese Unie - Hongaars - EMA (European Medicines Agency)

strangvac

intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - a lófélék immunológiai vizsgálata - lovak - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.

Tessie Europese Unie - Hongaars - EMA (European Medicines Agency)

tessie

orion corporation - tasipimidine sulfate - other hypnotics and sedatives - kutyák - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.

COVID-19 Vaccine (inactivated, adjuvanted) Valneva Europese Unie - Hongaars - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - a vakcinák - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Lutetium (177Lu) chloride Billev (previously Illuzyce) Europese Unie - Hongaars - EMA (European Medicines Agency)

lutetium (177lu) chloride billev (previously illuzyce)

billev pharma aps - lutetium (177lu) chloride - radionuklid képalkotás - terápiás radiofarmakonok - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Enjaymo Europese Unie - Hongaars - EMA (European Medicines Agency)

enjaymo

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - immunszuppresszánsok - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Talvey Europese Unie - Hongaars - EMA (European Medicines Agency)

talvey

janssen-cilag international n.v. - talquetamab - myeloma multiplex - daganatellenes szerek - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.